FrancophonIA/ELRC3.0 huggingface dataset:
English: - Buprenorphine/naloxone (medicines to treat opioid dependence) - Salmeterol (medicine to treat asthma) - Artemether/lumefantrine (a combination medicine to treat malaria) - Dasatinib, everolimus, irinotecan, nilotinib, vinblastine, vincristine (to treat cancer) - Sildenafil, tadalafil, vardenafil (for erectile dysfunction or to treat a heart and lung disorder called pulmonary arterial hypertension) - Glecaprevir/pibrentasvir, simeprevir (to treat hepatitis C infection) - Fentanyl, oxycodone, tramadol (to treat pain) - Fesoterodine, solifenacin (to treat urologic disorders).
Danish: - buprenorphin/naloxon (medicin til behandling af afhængighed af morfin og lignende) - salmeterol (medicin til behandling af astma) - artemether/lumefantrin (et kombinationspræparat til behandling af malaria) - dasatinib, everolimus, irinotecan, nilotinib, vinblastin, vincristin (til behandling af kræft) - sildenafil, tadalafil, vardenafil (til behandling af impotens eller til behandling af en hjerte/lungesygdom kaldet pulmonal arteriel hypertension) - glecaprevir/pibrentasvir, simeprevir (til behandling af hepatitis C-infektion) - fentanyl, oxycodon, tramadol (til behandling af smerter) - fesoterodin, solifenacin (til behandling af sygdomme i urinvejene).
English: For clinical trial results in ART-naïve paediatric patients aged 12 to 17 years, refer to the Summary of Product Characteristics for PREZISTA 400 mg and 800 mg tablets or PREZISTA 100 mg/ml oral suspension.
Danish: Vedrørende kliniske studieresultater for ART-naive pædiatriske patienter i alderen 12 til 17 år henvises til produktresuméet for PREZISTA 400 mg og 800 mg tabletter eller PREZIASTA 100 mg/ml oral suspension.
English: Concomitant use of other PDE-5 inhibitors for the treatment of erectile dysfunction with boosted PREZISTA should be done with caution.
Danish: Der skal udvises forsigtighed ved samtidig brug af andre PDE-5hæmmere til behandling af erektil dysfunktion og boostet PREZISTA.
English: PREZISTA 400 mg tablets contain sunset yellow FCF (E110) which may cause an allergic reaction.
Danish: PREZISTA 400 mg tabletter indeholder sunset yellow FCF (E110), som kan forårsage en allergisk reaktion.
English: PREZISTA should not be used in paediatric patients below 3 years of age or less than 15 kg body weight (see sections 4.4 and 5.3).
Danish: PREZISTA bør ikke anvendes til pædiatriske patienter under 3 år eller med en legemsvægt under 15 kg (se pkt.
English: The PREZISTA 800 milligram tablet is not for use in children younger than 3 years of age or weighing less than 40 kilograms.
Danish: Børn og unge PREZISTA 800 mg tabletten må ikke anvendes til børn under 3 år, eller som vejer mindre end 40 kg.
English: For additional clinical study results in ART-experienced adults and paediatric patients, refer to the Summary of Product Characteristics for PREZISTA 75 mg, 150 mg, 300 mg or 600 mg tablets and 100 mg/ml oral suspension.
Danish: Vedrørende yderligere kliniske studieresultater hos ART-erfarne voksne og pædiatriske patienter henvises til produktresuméet for PREZISTA 75 mg, 150 mg, 300 mg eller 600 mg tabletter samt 100 mg/ml oral suspension.
English: Cmax, ng/ml AUC24h, ng.h/ml Cmin, ng/ml
Danish: Cmax, ng/ml AUC24t, ng∙t/ml Cmin, ng/ml
English: Plasma concentrations of these medicinal products may be increased when co-administered with boosted PREZISTA, resulting in reduced serum cortisol concentrations.
Danish: Plasmakoncentrationen af disse lægemidler kan øges ved administration sammen med boostet PREZISTA, hvilket medfører nedsat serumcortisol.
English: Ethinylestradiol Norethindrone 35 g/1 mg once daily drospirenone AUC ↑ 58% drospirenone Cmin ND drospirenone Cmax ↑ 15% ethinylestradiol AUC  30% ethinylestradiol Cmin ND ethinylestradiol Cmax  14% with darunavir/cobicistat ethinylestradiol AUC ↓ 44% ethinylestradiol Cmin ↓ 62% ethinylestradiol Cmax ↓ 32% norethindrone AUC ↓ 14% norethindrone Cmin ↓ 30% norethindrone Cmax ↔ with darunavir/ritonavir
Danish: drospirenon AUC ↑ 58 % drospirenon Cmin ND drospirenon Cmax ↑ 15 % ethinylestradiol AUC  30 % ethinylestradiol Cmin ND ethinylestradiol Cmax  14 % med darunavir/cobicistat ethinylestradiol AUC ↓ 44 % ethinylestradiol Cmin ↓ 62 % ethinylestradiol Cmax ↓ 32 % norethindron AUC ↓ 14 % norethindron Cmin ↓ 30 % norethindron Cmax  med darunavir/ritonavir
English: Co-administration of domperidone with boosted PREZISTA is contraindicated.
Danish: Co-administration af domperidon og boostet PREZISTA er kontraindiceret.
English: Low rates of developing resistant HIV-1 virus were observed in ART-naïve patients who are treated for the first time with darunavir/cobicistat once daily in combination with other ART, and in ART-experienced patients with no darunavir RAMs receiving darunavir/cobicistat in combination with other ART.
Danish: Lave forekomster af udvikling af resistent hiv-1-virus blev observeret hos ART-naive patienter, som blev behandlet første gang med darunavir/cobicistat en gang dagligt i kombination med andre ART, og hos ART-erfarne patienter uden darunavir-RAMs, som fik darunavir/cobicistat i kombination med andre ART. Tabellen nedenfor viser udviklingen af hiv-1 protease-mutationer og resistens over for PI'er ved virologiske svigt ved endepunktet i GS-US-216-130-studiet.
English: • 80 ART-experienced HIV-1 infected paediatric patients aged from 6 to 17 years and weighing at least 20 kg who received PREZISTA tablets with low dose ritonavir twice daily in combination with other antiretroviral agents.
Danish: ● 80 ART-erfarne hiv-1-smittede pædiatriske patienter i alderen 6 til 17 år med en legemsvægt på mindst 20 kg som blev behandlet med PREZISTA tabletter sammen med lavdosis ritonavir to gange dagligt i kombination med andre antiretrovirale lægemidler.
English: Clinical monitoring of therapeutic and adverse effects is recommended when these medicines are concomitantly administered with PREZISTA with low dose ritonavir.
Danish: Klinisk monitorering af terapeutiske og uønskede virkninger anbefales, når disse lægemidler administreres sammen med PREZISTA og lavdosis ritonavir.
English: Caution is warranted and therapeutic concentration monitoring, if available, is recommended for these antiarrhythmics when co-administered with PREZISTA with low dose ritonavir.
Danish: Der skal udvises forsigtighed, og om muligt anbefales monitorering af terapeutisk koncentration for disse antiarytmika ved coadministration med PREZISTA med lavdosis ritonavir.
English: • 12 ART-naïve HIV-1 infected paediatric patients aged from 12 to 17 years and weighing at least 40 kg who received PREZISTA tablets with low dose ritonavir once daily in combination with other antiretroviral agents (see section 5.1).
Danish: ● 12 ART-naive hiv-1-smittede pædiatriske patienter i alderen 12 til 17 år med en legemsvægt på mindst 40 kg, som fik PREZISTA tabletter sammen med lavdosis ritonavir en gang dagligt i kombination med andre antiretrovirale lægemidler (se pkt.
English: Gastrointestinal disorders very common diarrhoea common vomiting, nausea, abdominal pain, increased blood amylase, dyspepsia, abdominal distension, flatulence uncommon pancreatitis, gastritis, gastrooesophageal reflux disease, aphthous stomatitis, retching, dry mouth, abdominal discomfort, constipation, increased lipase, eructation, oral dysaesthesia rare stomatitis, haematemesis, cheilitis, dry lip, coated tongue
Danish: Mave-tarm-kanalen meget almindelig diarré almindelig opkastning, kvalme, abdominale smerter, forhøjet blodamylase, dyspepsi, abdominal distention, flatulens ikke almindelig pankreatitis, gastritis, gastroøsofageal reflukssygdom, aftøs stomatitis, opkastningsfornemmelser, mundtørhed, mavebesvær, forstoppelse, forhøjet lipase, ræben, oral dysæstesi,
English: Pharmacokinetic enhancer and concomitant medications Darunavir has different interaction profiles depending on whether the compound is boosted with ritonavir or cobicistat: - Darunavir boosted with cobicistat is more sensitive for CYP3A induction: concomitant use of darunavir/cobicistat and strong CYP3A inducers is therefore contraindicated (see section 4.3), and concomitant use with weak to moderate CYP3A inducers is not recommended (see section 4.5).
Danish: Farmakokinetisk forstærker og samtidige lægemidler Darunavir har forskellige interaktionsprofiler afhængigt af, om stoffet boostes med ritonavir eller cobicistat: - Darunavir boostet med cobicistat er mere følsomt for CYP3A-induktion: samtidig brug af darunavir/cobicistat og potente CYP3A-induktorer er derfor kontraindiceret (se pkt.
English: ethinylestradiol AUC ↓ 44% ethinylestradiol Cmin ↓ 62% ethinylestradiol Cmax ↓ 32% norethindrone AUC ↓ 14% norethindrone Cmin ↓ 30% norethindrone Cmax ↔ with darunavir/ritonavir
Danish: ethinylestradiol AUC ↓ 44 % ethinylestradiol Cmin ↓ 62 % ethinylestradiol Cmax ↓ 32 % norethindron AUC ↓ 14 % norethindron Cmin ↓ 30 % norethindron Cmax 
English: Excipient with known effect: Each tablet contains 1.375 mg sunset yellow FCF (E110).
Danish: Hjælpestof, som behandleren skal være opmærksom på: Hver tablet indeholder 1,375 mg sunset yellow FCF (E110).
English: Musculoskeletal and connective tissue disorders uncommon myalgia, osteonecrosis, muscle spasms, muscular weakness, arthralgia, pain in extremity, osteoporosis, increased blood creatine phosphokinase rare musculoskeletal stiffness, arthritis, joint stiffness
Danish: Knogler, led, muskler og bindevæv ikke almindelig myalgi, osteonekrose, muskelspasmer, muskelsvaghed, artralgi, smerter i ekstremiteter, osteoporose, forhøjet kreatinkinase i blodet sjælden stivhed i skeletmuskulaturen, artritis, ledstivhed
English: HIV-1 RNA < 50 copies/ml CD4+ percent change from baseline CD4+ cell count mean change from baseline ≥ 1.0 log10 decrease from baseline in plasma viral load
Danish: Hiv-1 RNA < 50 kopier/ml CD4+ procent ændring fra baseline CD4+-celletal gennemsnitlig ændring fra baseline ≥ 1.0 log10 fald fra baseline i viral load i plasma
English: The bottle neck is filled with a low density polyethylene (LDPE) insert that accommodates the dosing pipette.
Danish: Flaskehalsen udfyldes af en LDPE-indsats til placering af doseringssprøjten.
English: zoldipem (sedative agents) - Perphenazine, risperidone, thioridazine (to treat psychiatric conditions).
Danish: zoldipem (beroligende midler) - perphenazin, risperidon, thioridazin (til behandling af psykiske lidelser).
English: You must take PREZISTA every day and always in combination with 150 milligram of cobicistat or 100 milligram of ritonavir and with food.
Danish: Du skal tage PREZISTA hver dag og altid i kombination med 150 mg cobicistat eller 100 mg ritonavir samt mad.
English: Plasma concentrations of these medicinal products may be increased when co-administered with PREZISTA with low dose ritonavir, resulting in reduced serum cortisol concentrations.
Danish: Plasmakoncentrationen af disse lægemidler kan øges ved administration sammen med PREZISTA med lavdosis ritonavir, hvilket medfører nedsat serumcortisol.
English: prezista 75 mg (this is only applicable to the outer pack)
Danish: prezista 75 mg (kun på yderpakningen)
English: The interaction trial showed a comparable daily systemic exposure for rifabutin between treatment at 300 mg once daily alone and 150 mg once every other day in combination with PREZISTA/ritonavir (600/100 mg twice daily) with an about 10-fold increase in the daily exposure to the active metabolite 25-O-desacetylrifabutin.
Danish: Interaktionsstudiet viste en sammenlignelig daglig systemisk eksponering af rifabutin imellem behandling med 300 mg x 1 og 150 mg hver anden dag i kombination med PREZISTA/ritonavir (600/100 mg x 2).
English: Concomitant systemic use of clotrimazole and boosted PREZISTA may increase plasma concentrations of darunavir and/or clotrimazole.
Danish: Samtidig systemisk brug af clotrimazol og boostet PREZISTA kan øge plasmakoncentrationen af darunavir og/eller clotrimazol.
English: 600 milligram (6 milliliter)
Danish: 600 mg (6 ml)
English: PREZISTA cannot work properly without cobicistat or ritonavir and food.
Danish: PREZISTA kan ikke virke korrekt uden cobicistat eller ritonavir og mad.
English: This can be seen in a blood test. - high blood pressure, flushing - red or dry eyes - fever, swelling of lower limbs due to fluids, malaise, irritability, pain - symptoms of infection, herpes simplex - erectile dysfunction, enlargement of breasts - sleeping problems, sleepiness, depression, anxiety, abnormal dreams, decrease in sexual drive
Danish: - forhøjet blodtryk, rødme - røde eller tørre øjne - feber, hævede ben på grund af væske, utilpashed, irritabilitet, smerte - symptomer på infektion, herpes simplex - impotens, større bryster - søvnproblemer, søvnighed, depression, angst, unormale drømme, nedgang i seksuallyst.
English: Therefore, co-administration of PREZISTA with low dose ritonavir and sildenafil when used for the treatment of pulmonary arterial hypertension is contraindicated (see section 4.3).
Danish: Co-administration af PREZISTA, lavdosis ritonavir og sildenafil til behandling af pulmonal arteriel hypertension er derfor kontraindiceret (se pkt.
English: PREZISTA is an antiretroviral medicine used in the treatment of Human Immunodeficiency Virus (HIV) infection.
Danish: PREZISTA anvendes til behandling af hiv-infektion (hiv: humant immundefektvirus).
English: Co-administration of boosted PREZISTA with these anticoagulants may increase concentrations of the anticoagulant, which may lead to an increased bleeding risk.
Danish: Co-administration af boostet PREZISTA med disse antikoagulantia kan øge koncentrationerne af antikoagulanset hvilket kan medføre en øget blødningsrisiko.
English: If parenteral midazolam is co-administered with PREZISTA co-administered with low dose ritonavir it may cause a large increase in the concentration of this benzodiazepine.
Danish: Co-administration af parenteral midazolam med PREZISTA co-administreret med lavdosis ritonavir kan give en kraftig forøgelse af koncentrationen af dette benzodiazepin.
English: Medicinal products that induce CYP3A activity would be expected to increase the clearance of darunavir and ritonavir, resulting in lowered plasma concentrations of these compounds and consequently that of darunavir, leading to loss of therapeutic effect and possible development of resistance (see sections 4.3 and 4.4).
Danish: Lægemidler, som inducerer CYP3A-aktivitet, må forventes at øge darunavir- og ritonavir-clearance, hvilket ville forårsage reducerede plasmakoncentrationer af disse stoffer og dermed af darunavir, med efterfølgende tab af terapeutisk effekt og mulig resistensudvikling (se pkt.
English: PREZISTA cannot work properly without cobicistat or ritonavir.
Danish: PREZISTA virker ikke korrekt uden cobicistat eller ritonavir.
English: PREZISTA is not recommended for use in paediatric patients below 3 years of age or less than 15 kg body weight (see sections 4.2 and 5.3).
Danish: PREZISTA anbefales ikke til brug til pædiatriske patienter under 3 år eller med en legemsvægt under 15 kg (se pkt.
English: If you take more PREZISTA than you should Contact your doctor, pharmacist or nurse immediately.
Danish: Hvis du har taget for meget PREZISTA Kontakt straks din læge, apotekspersonalet eller sundhedspersonalet.
English: The film-coating contains poly(vinyl alcohol) - partially hydrolysed, macrogol 3350, titanium dioxide (E171), talc, iron oxide red (E172).
Danish: Filmovertrækket indeholder polyvinylalkohol - delvist hydrolyseret, macrogol 3350, titandioxid (E171), talcum, rød jernoxid (E172).
English: Nevirapine 200 mg twice daily nevirapine AUC ↑ 27% nevirapine Cmin ↑ 47% nevirapine Cmax ↑ 18% darunavir: concentrations were consistent with historical data (↑ nevirapine from CYP3A inhibition)
Danish: nevirapin AUC ↑ 27 % nevirapin Cmin ↑ 47 % nevirapin Cmax ↑ 18 % darunavir: koncentrationerne var i overensstemmelse med historiske data.
English: PREZISTA must be taken in combination with a low dose of cobicistat or ritonavir and other anti-HIV medicines.
Danish: PREZISTA skal tages i kombination med en lavdosis cobicistat eller ritonavir og anden hiv-medicin.
English: The combination of rifapentine and PREZISTA with concomitant low dose ritonavir is not recommended.
Danish: Kombinationen af rifapentin og PREZISTA med samtidig lavdosis ritonavir frarådes.
English: 50 milligram (0.6 milliliter)
Danish: 50 mg (0,6 ml)
English: HIV ANTIRETROVIRALS Integrase strand transfer inhibitors Dolutegravir dolutegravir AUC ↓ 22% dolutegravir C24h ↓ 38% dolutegravir Cmax ↓ 11% darunavir ↔*
Danish: Dolutegravir dolutegravir AUC ↓ 22 % dolutegravir C24h ↓ 38 % dolutegravir Cmax ↓ 11 % darunavir ↔*
English: PREZISTA/ritonavir should be used during pregnancy only if the potential benefit justifies the potential risk (see sections 4.4, 4.6 and 5.2).
Danish: PREZISTA/ritonavir bør kun anvendes under graviditet, hvis den mulige fordel opvejer den mulige risiko (se pkt.
English: The film-coating contains poly(vinyl alcohol) - partially hydrolysed, macrogol 3350, titanium dioxide (E171), talc.
Danish: Filmovertrækket indeholder polyvinylalkohol - delvist hydrolyseret, macrogol 3350, titandioxid (E171), talcum.
English: Tell your doctor if you take: - Phenobarbital, phenytoin (to prevent seizures) - Dexamethasone (corticosteroid) - Efavirenz (HIV infection) - Boceprevir (hepatitis C infection) - Rifapentine, rifabutin (medicines to treat some infections such as tuberculosis) - Saquinavir (HIV infection).
Danish: Du skal fortælle din læge, hvis du tager: - phenobarbital, phenytoin (til forebyggelse af krampeanfald) - dexamethason (kortikosteroid) - efavirenz (til hiv-infektion) - boceprevir (til hepatitis C-infektion) - rifapentin, rifabutin (medicin til behandling af visse infektioner som f.eks. tuberkolose) - saquinavir (til hiv-infektion).
English: Boosted PREZISTA must not be used concomitantly with products containing St John's wort (Hypericum perforatum) (see section 4.3).
Danish: Boostet PREZISTA må ikke anvendes samtidig med produkter, der indeholder perikon (Hypericum perforatum) (se pkt.
English: PREZISTA tablets contain sunset yellow FCF (E110) which may cause allergic reactions.
Danish: PREZISTA-tabletter indeholder sunset yellow FCF (E110), som kan medføre allergiske reaktioner.
English: Clinical monitoring is recommended when co-administering boosted PREZISTA with these antidepressants and a dose adjustment of the antidepressant may be needed.
Danish: Klinisk monitorering anbefales ved co-administration af boostet PREZISTA med disse antidepressiva, og det kan være nødvendigt at justere dosis af antidepressivummet.
English: See the Summary of Product Characteristics for PREZISTA 75 mg, 150 mg, 300 mg and 600 mg tablets (see section 4.5).
Danish: Se produktresuméet for PREZISTA 75 mg, 150 mg, 300 mg og 600 mg tabletter (se pkt.
English: It is not recommended to co-administer PREZISTA with low dose ritonavir and boceprevir.
Danish: Det anbefales ikke at co-administrere PREZISTA med lavdosis ritonavir og boceprevir.
English: Darunavir co-administered with low dose ritonavir must not be combined with medicinal products that are highly dependent on CYP3A for clearance and for which increased systemic exposure is associated with serious and/or life-threatening events (narrow therapeutic index) (see section 4.3).
Danish: Darunavir co-administreret med lavdosis ritonavir må ikke kombineres med lægemidler, der er meget afhængige af CYP3A i forbindelse med clearance, og for hvilke øget systemisk eksponering er forbundet med alvorlige og/eller livstruende hændelser (snævert terapeutisk indeks) (se pkt.
English: Efavirenz in combination with boosted PREZISTA once daily may result in sub-optimal darunavir Cmin.
Danish: Efavirenz i kombination med boostet PREZISTA en gang dagligt kan medføre suboptimal darunavir Cmin.
English: 60 milligram (0.8 milliliter)
Danish: 60 mg (0,8 ml)
English: Concominant administration of PREZISTA with low dose ritonavir and lurasidone, pimozide or sertindole is contraindicated (see section 4.3).
Danish: Samtidig administration af PREZISTA med lavdosis ritonavir og lurasidon, pimozid eller sertindol er kontraindiceret (se pkt.
English: Skin and subcutaneous tissue disorders common rash (including macular, maculopapular, papular, erythematous and pruritic rash), pruritus uncommon angioedema, generalised rash, allergic dermatitis, urticaria, eczema, erythema, hyperhidrosis, night sweats, alopecia, acne, dry skin, nail pigmentation rare
Danish: Hud og subkutane væv almindelig udslæt (herunder makuløst, makulopapuløst, papuløst, erytematøst og kløende udslæt), kløe ikke almindelig angioødem, generaliseret udslæt, allergisk dermatitis, nældefeber, eksem, erytem, hyperhidrose, nattesved, alopeci, akne, tør hud, neglepigmentering sjælden
English: If you take PREZISTA two times a day and if you notice within 6 hours, you must take the oral suspension immediately.
Danish: Hvis du tager PREZISTA to gange dagligt, og du kommer i tanke om den glemte dosis inden for 6 timer, skal du straks tage en dosis.
English: Concominant use of everolimus or irinotecan and PREZISTA co-administered with low dose ritonavir is not recommended.
Danish: Samtidig brug af everolimus eller irinotecan og PREZISTA coadministreret med lavdosis ritonavir frarådes.
English: 800 milligram (8 milliliter)
Danish: 800 mg (8 ml)
English: Based on normal approximation to the difference in % response Non-completer is failure imputation: patients who discontinued prematurely are imputed with a change equal to 0
Danish: I henhold til TLOVR-algoritmen (time to loss of vrtal response) Baseret på en normal approksimation af forskellen i % respons Patienter, der ikke fuldførte behandlingen, betragtes som havende behandlingssvigt, dvs. patienter der afbrød behandlingen i utide medregnes med en ændring, der tillægges størrelsen 0.
English: ART-naïve paediatric patients from the age of 12 years to < 18 years, and weighing at least 40 kg DIONE is an open-label, Phase II trial evaluating the pharmacokinetics, safety, tolerability, and efficacy of PREZISTA with low dose ritonavir in 12 ART-naïve HIV-1 infected paediatric patients aged 12 to less than 18 years and weighing at least 40 kg.
Danish: ART-naive pædiatriske patienter i alderen 12 år til < 18 år og legemsvægt mindst 40 kg DIONE er et åbent fase II-studie til evaluering af farmakokinetik, sikkerhed, tolerabilitet og effekt af PREZISTA sammen med lavdosis ritonavir hos 12 ART-naive hiv-1-smittede pædiatriske patienter i alderen 12 år til < 18 år med en legemsvægt på mindst 40 kg.
English: Boosted PREZISTA and didanosine can be used without dose adjustments.
Danish: Boostet PREZISTA og didanosin kan administreres uden dosisjusteringer.
English: PREZISTA, co-administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of patients with human immunodeficiency virus (HIV-1) infection.
Danish: PREZISTA, administreret sammen med lavdosis ritonavir, er i kombination med andre antiretrovirale lægemidler indiceret til behandling af patienter med human immundefektvirus (hiv-1)-infektion.
English: 480 tablets in a plastic bottle.
Danish: 480 tabletter i en plasttabletbeholder.
English: Concomitant use of PREZISTA with low dose ritonavir and elbasvir/grazoprevir is contraindicated (see section 4.3).
Danish: Samtidig brug af PREZISTA med lavdosis ritonavir og elbasvir/grazoprevir er kontraindiceret (se pkt.
English: PREZISTA cannot work properly without ritonavir and food.
Danish: PREZISTA virker ikke korrekt uden ritonavir og mad.
English: Also contains sunset yellow FCF (E110).
Danish: Indeholder også sunset yellow FCF (E110).
English: PREZISTA 400 mg film-coated tablets PREZISTA 800 mg film-coated tablets
Danish: PREZISTA 400 mg filmovertrukne tabletter PREZISTA 800 mg filmovertrukne tabletter
English: - Take PREZISTA always together with 150 milligram of cobicistat or 100 milligram of ritonavir.
Danish: - Tag altid PREZISTA sammen med 150 mg cobicistat eller 100 mg ritonavir.
English: It is not recommended to co-administer boosted PREZISTA and boceprevir.
Danish: Det anbefales ikke at co-administrere boostet PREZISTA og boceprevir.
English: Excipient with known effect: Each tablet contains a maximum of 2.750 mg sunset yellow FCF (E110).
Danish: Hjælpestof, som behandleren skal være opmærksom på: Hver tablet indeholder 2,750 mg sunset yellow FCF (E110).